Neogen Stock Today
| NEOG Stock | USD 10.27 0.02 0.20% |
PerformanceSolid
| Odds Of DistressSmall
|
Neogen is trading at 10.27 as of the 3rd of February 2026. This is a 0.20% increase since the beginning of the trading day. The stock's lowest day price was 10.25. Neogen has about a 29 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. The performance scores are derived for the period starting the 5th of November 2025 and ending today, the 3rd of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 23rd of August 1989 | Category Healthcare | Classification Health Care |
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 217.53 M outstanding shares of which 14.1 M shares are now shorted by private and institutional investors with about 3.32 trading days to cover. More on Neogen
Moving against Neogen Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Neogen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Mike Nassif | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite Total, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsNeogen utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Neogen's leverage profile, showing how much of Neogen's resources are funded through borrowing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Neogen (NEOG) is traded on NASDAQ Exchange in USA and employs 2,974 people. Neogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.22 B. Neogen conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 217.53 M outstanding shares of which 14.1 M shares are now shorted by private and institutional investors with about 3.32 trading days to cover.
Neogen currently holds about 347.71 M in cash with 58.24 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22.
Check Neogen Probability Of Bankruptcy
Ownership AllocationThe majority of Neogen outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Neogen to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Neogen. Please pay attention to any change in the institutional holdings of Neogen as this could imply that something significant has changed or is about to change at the company.
Check Neogen Ownership Details
Neogen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 6.2 M | |
| Geode Capital Management, Llc | 2025-06-30 | 5.1 M | |
| Fred Alger Management, Llc | 2025-06-30 | 4.2 M | |
| King Luther Capital Management Corp | 2025-06-30 | 3.4 M | |
| Bank Of America Corp | 2025-06-30 | 3.4 M | |
| American Capital Management Inc | 2025-06-30 | 3.3 M | |
| Ubs Group Ag | 2025-06-30 | 3.3 M | |
| Shapiro Capital Management Co Inc | 2025-06-30 | 3.3 M | |
| Ameriprise Financial Inc | 2025-06-30 | 3.1 M | |
| Blackrock Inc | 2025-06-30 | 30.6 M | |
| Vanguard Group Inc | 2025-06-30 | 23.6 M |
Neogen Historical Income Statement
Neogen Stock Against Markets
Neogen Corporate Management
| Dr MBA | Chief Officer | Profile | |
| Jeremy Yarwood | Chief Officer | Profile | |
| Tamara Ranalli | Senior Safety | Profile | |
| David Naemura | Executive Officer | Profile | |
| Bill Waelke | Head Relations | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Neogen have expansion opportunities? Factors like these will boost the valuation of Neogen. Anticipated expansion of Neogen directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Neogen demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.86) | Earnings Share (2.78) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
Investors evaluate Neogen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Neogen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Neogen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Neogen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neogen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Neogen's market price signifies the transaction level at which participants voluntarily complete trades.